1072103-29-7 Usage
Uses
Used in Pharmaceutical Industry:
5-Morpholinopicolinic acid is used as a key intermediate in the synthesis of pharmaceuticals for its potential anti-inflammatory and anti-tumor properties. Its unique structure allows it to be a versatile building block in the development of new drugs targeting a range of health conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Morpholinopicolinic acid is utilized as a precursor in the production of agrochemicals. Its incorporation into these products can enhance their effectiveness in protecting crops from pests and diseases, thereby contributing to increased agricultural productivity.
Used in Research and Development:
5-Morpholinopicolinic acid is also used as a research compound in various scientific studies. Its potential applications in the pharmaceutical and agricultural industries make it a valuable subject for exploration, with ongoing research aimed at uncovering new uses and optimizing its properties for specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1072103-29-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,2,1,0 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1072103-29:
(9*1)+(8*0)+(7*7)+(6*2)+(5*1)+(4*0)+(3*3)+(2*2)+(1*9)=97
97 % 10 = 7
So 1072103-29-7 is a valid CAS Registry Number.
1072103-29-7Relevant academic research and scientific papers
N1-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS
-
, (2011/05/16)
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions there-of; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl- CoA carboxylase enzyme(s) in an animal
N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS
-
, (2011/06/16)
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl- CoA carboxylase enzyme(s) in an animal.
